TOKYO, Feb 10 (Reuters) - German drug company Boehringer Ingelheim is in talks to make Japanese subsidiary SSP Co Ltd 4537.T wholly-owned in a deal worth more than 30 billion yen ($335 million), the Nikkei newspaper reported.
Boehringer currently owns 60 percent of SSP, a maker of over-the-counter drugs.
Boehringer is expected to buy the remaining stake in a tender offer as early as the end of this month, the Nikkei said.
Tetsuya Owari, a spokesman for Boehringer in Japan, said nothing had been decided. He declined to elaborate.
email@example.com; +813-6441-1801; Reuters Messaging: firstname.lastname@example.org
Our Standards: The Thomson Reuters Trust Principles.